Common variant of farnesoid-x-receptor gene enhances the response to lipid-lowering therapy

被引：0
|
作者：
Nohara, A.
Tada, H.
Katsuda, S.
Kawashiri, M.
Inazu, A.
Kobayashi, J.
Yamagishi, M.
Mabuchi, M.
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Lipidol, Kanazawa, Ishikawa 920, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Div Cardiovasc Med, Kanazawa, Ishikawa 920, Japan
[3] Kanazawa Univ, Sch Hlth Sci, Kanazawa, Ishikawa 920, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)70966-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [41] Individual and interactive effects of three common polymorphisms in APOA1 gene and obesity on lipid-lowering efficacy of statin
    Liu, Yu
    Venners, Scott
    Jiang, Shanqun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 461 - 462
  • [42] The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin
    Hu, Miao
    Lui, Sandra S. H.
    Tam, Lai-Shan
    Li, Edmund K.
    Tomlinson, Brian
    JOURNAL OF LIPID RESEARCH, 2012, 53 (07) : 1384 - 1389
  • [43] DOES PREVIOUS ANGIOPLASTY OF A CORONARY LESION INFLUENCE ITS SUBSEQUENT RESPONSE TO LIPID-LOWERING THERAPY - A CCAIT SUBSTUDY
    WATERS, D
    GLADSTONE, P
    HIGGINSON, L
    BOCCUZZI, S
    COOK, T
    LESPERANCE, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A403 - A403
  • [44] Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus
    Tavintharan, S.
    Lim, S. C.
    Chan, Y. H.
    Sum, C. F.
    DIABETES OBESITY & METABOLISM, 2007, 9 (01): : 81 - 86
  • [45] Serum Resistin is not Associated with the Response to Lipid-Lowering Therapy in Non-Diabetic Patients with Coronary Artery Disease
    Lee, Sahmin
    Kim, Yoon-Ki
    Kwon, Yoo-Wook
    Yang, Han-Mo
    Cho, Hyun-Jai
    Oh, Byung-Hee
    Park, Young-Bae
    Kim, Hyo-Soo
    CIRCULATION, 2012, 126 (21)
  • [46] SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians
    Sortica, Vinicius A.
    Fiegenbaum, Marilu
    Lima, Luciana O.
    Van der Sand, Cezar R.
    Van der Sand, Luis C.
    Ferreira, Maria E. W.
    Pires, Renan C.
    Hutz, Mara H.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (03) : 441 - 448
  • [47] Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
    Vanwong, Natchaya
    Tipnoppanon, Sayanit
    Nakorn, Chalitpon Na
    Srisawasdi, Pornpen
    Rodcharoen, Punyanuch
    Medhasi, Sadeep
    Chariyavilaskul, Pajaree
    Siwamogsatham, Sarawut
    Vorasettakarnkij, Yongkasem
    Sukasem, Chonlaphat
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 119 - 130
  • [48] Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy
    Ballantyne, CM
    Herd, JA
    Stein, EA
    Ferlic, LL
    Dunn, JK
    Gotto, AM
    Marian, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) : 1572 - 1578
  • [49] Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy
    Zambon, A
    Brown, BG
    Hokanson, JE
    Motulsky, AG
    Brunzell, JD
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (04) : 401 - 409
  • [50] Persistent Cigarette Smoking Attenuates Plaque Stabilization in Response to Lipid-Lowering Therapy: A Serial Optical Coherence Tomography Study
    Zhang, Xiling
    Peng, Xiang
    Li, Lulu
    Yu, Huai
    Yu, Bo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
12345